,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,155,1,1,,72179,10364,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
1,157,1,1,,72179,10364,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
2,161,1,1,,72179,10364,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
3,165,1,1,,72179,10364,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
4,167,1,1,,72179,10364,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
5,175,1,1,,72179,10364,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
6,114276,3,3,,103199240,10364,Unspecified,,,,,Hypnotic activity was measured as dose which causes loss of righting reflex for a minimum period of 30s in 50% of mice; Range is 30-40,Other,7452689.0,
7,116736,6,2,,103199240,10364,Unspecified,,,,,Acute toxicity measured as median lethal dose in mice; Range is 80-100,Other,7452689.0,
8,214939,7,3,,103199240,10364,Unspecified,,,1500.0,Km,Binding affinity against human UDP Glucuronosyltransferase 1A4 (UGT1A4),Confirmatory,12699380.0,
9,403341,11,1,,103199240,10364,Active,,,4.0,IC50,Inhibition of COX1,Confirmatory,16038536.0,
10,482143,6,6,,103199240,10364,Active,313104269.0,8989.0,7.0,EC50,Agonist activity at human TRPA1 channel expressed in HEK293 cells assessed as increase in intracellular calcium influx,Confirmatory,20356305.0,
11,624606,1,9,,103199240,10364,Unspecified,136729.0,54658.0,,,Specific activity of expressed human recombinant UGT1A1,Other,10836148.0,
12,624608,3,2,,103199240,10364,Unspecified,136731.0,54657.0,,,Specific activity of expressed human recombinant UGT1A4,Other,10836148.0,
13,624609,1,9,,103199240,10364,Unspecified,29840832.0,54578.0,,,Specific activity of expressed human recombinant UGT1A6,Other,10836148.0,
14,624611,1,9,,103199240,10364,Unspecified,29839637.0,54576.0,,,Specific activity of expressed human recombinant UGT1A8,Other,10836148.0,
15,624612,1,9,,103199240,10364,Unspecified,29839451.0,54600.0,,,Specific activity of expressed human recombinant UGT1A9,Other,10836148.0,
16,624613,1,9,,103199240,10364,Unspecified,29839636.0,54575.0,,,Specific activity of expressed human recombinant UGT1A10,Other,10836148.0,
17,624614,1,8,,103199240,10364,Unspecified,296452854.0,10941.0,,,Specific activity of expressed human recombinant UGT2A1,Other,10836148.0,
18,624616,1,8,,103199240,10364,Unspecified,332278237.0,7366.0,,,Specific activity of expressed human recombinant UGT2B15,Other,10836148.0,
19,651631,4,1,,144211695,10364,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
20,651632,4,1,,144211695,10364,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
21,651633,4,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
22,651634,4,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
23,677530,1,2,,103199240,10364,Unspecified,,,,,Insecticidal activity against 5th instar nymph of Dysdercus koenigii assessed as mortality per nymph,Other,22850211.0,
24,677534,2,2,,103199240,10364,Unspecified,,,,,Antifungal activity against Magnaporthe grisea after 48 hrs by microbroth dilution method,Other,22850211.0,
25,677535,2,2,,103199240,10364,Unspecified,,,,,Antifungal activity against Fusarium oxysporum after 48 hrs by microbroth dilution method,Other,22850211.0,
26,677536,2,2,,103199240,10364,Unspecified,,,,,Antifungal activity against Dreschlera oryzae after 48 hrs by microbroth dilution method,Other,22850211.0,
27,677537,2,2,,103199240,10364,Unspecified,,,,,Antifungal activity against Debaryomyces hansenii after 48 hrs by microbroth dilution method,Other,22850211.0,
28,677538,2,2,,103199240,10364,Unspecified,,,,,Antifungal activity against Pichia membranifaciens after 48 hrs by microbroth dilution method,Other,22850211.0,
29,677539,3,1,,103199240,10364,Unspecified,,,,,Antifungal activity against Candida albicans NCIM 3557 after 48 hrs by microbroth dilution method,Other,22850211.0,
30,677610,3,1,,103199240,10364,Unspecified,,,,,Antifungal activity against Candida albicans after 48 hrs by microbroth dilution method,Other,22850211.0,
31,677611,3,1,,103199240,10364,Unspecified,,,,,Antifungal activity against Candida albicans NCIM 3471 after 48 hrs by microbroth dilution method,Other,22850211.0,
32,677612,3,1,,103199240,10364,Unspecified,,,,,Antifungal activity against Candida glabrata NCIM 3237 after 48 hrs by microbroth dilution method,Other,22850211.0,
33,677613,3,1,,103199240,10364,Unspecified,,,,,Antifungal activity against Cryptococcus neoformans after 48 hrs by microbroth dilution method,Other,22850211.0,
34,677614,3,1,,103199240,10364,Unspecified,,,,,Antifungal activity against Cryptococcus neoformans NCIM 3541 after 48 hrs by microbroth dilution method,Other,22850211.0,
35,677615,3,1,,103199240,10364,Unspecified,,,,,Antifungal activity against Cryptococcus neoformans NCIM 3542 after 48 hrs by microbroth dilution method,Other,22850211.0,
36,677616,3,1,,103199240,10364,Unspecified,,,,,Antifungal activity against Cryptococcus neoformans NCIM 3378 after 48 hrs by microbroth dilution method,Other,22850211.0,
37,677617,3,1,,103199240,10364,Unspecified,,,,,Toxicity in RBC assessed as induction of hemolysis,Other,22850211.0,
38,716615,1,3,,103199240,10364,Active,,,,,Reduction in peak-to-peak amplitude of compound action potential in Wistar rat sciatic nerve at 1 mM after 180 mins by electrophysiology,Other,22967040.0,
39,716616,1,3,,103199240,10364,Inactive,,,,,Reduction in peak-to-peak amplitude of compound action potential in Wistar rat sciatic nerve at 1 mM after 180 mins and measured after 180 mins washout by electrophysiology,Other,22967040.0,
40,716617,1,3,,103199240,10364,Inactive,,,,,Reduction in peak-to-peak amplitude of compound action potential in Wistar rat sciatic nerve at 0.3 mM after 180 mins by electrophysiology,Other,22967040.0,
41,716618,2,3,,103199240,10364,Unspecified,,,500.0,IC50,Reduction in peak-to-peak amplitude of compound action potential in Wistar rat sciatic nerve after 180 mins by electrophysiology,Confirmatory,22967040.0,
42,716619,1,3,,103199240,10364,Active,,,,,Inhibition of first component amplitude of compound action potential in Wistar rat Aalpha sciatic nerve after 180 mins by electrophysiology,Other,22967040.0,
43,716620,1,3,,103199240,10364,Active,,,,,Inhibition of second component amplitude of compound action potential in Wistar rat Abeta and Agamma sciatic nerve within 60 mins by electrophysiology,Other,22967040.0,
44,716621,1,2,,103199240,10364,Unspecified,,,,,Induction of Wistar rat sciatice nerve fiber excitability assessed as increase in rheobase at 0.6 mM (Rvb = 3.30 +/- 0.06 V),Other,22967040.0,
45,716812,1,2,,103199240,10364,Unspecified,,,,,Induction of Wistar rat sciatice nerve fiber excitability assessed as increase in chronaxy measured as time at 0.6 mM (Rvb = 59.6 +/- 1.2 microsec),Other,22967040.0,
46,716813,1,3,,103199240,10364,Unspecified,,,,,Reduction in amplitude of compound action potential in bullfrog sciatic nerve at 0.5 mM after 15 mins by electrophysiology,Other,22967040.0,
47,716814,2,3,,103199240,10364,Unspecified,,,500.0,IC50,Reduction in amplitude of compound action potential in frog sciatic nerve by electrophysiology,Confirmatory,22967040.0,
48,716815,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as amplitude reduction at 0.03 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = 79 +/- 1.3 mV),Other,22967040.0,
49,716816,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as amplitude reduction at 0.1 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = 79 +/- 1.3 mV),Other,22967040.0,
50,716817,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as amplitude reduction at 0.3 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = 79 +/- 1.3 mV),Other,22967040.0,
51,716818,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as amplitude reduction at 0.6 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = 79 +/- 1.3 mV),Other,22967040.0,
52,716819,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as amplitude reduction at 1 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = 79 +/- 1.3 mV),Other,22967040.0,
53,716820,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as amplitude reduction at 3 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = 79 +/- 1.3 mV),Other,22967040.0,
54,716821,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as resting potential at 0.03 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = -60 +/- 1.1 mV),Other,22967040.0,
55,716822,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as resting potential at 0.1 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = -60 +/- 1.1 mV),Other,22967040.0,
56,716823,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as resting potential at 0.3 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = -60 +/- 1.1 mV),Other,22967040.0,
57,716824,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as resting potential at 0.6 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = -60 +/- 1.1 mV),Other,22967040.0,
58,716825,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as resting potential at 1 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = -60 +/- 1.1 mV),Other,22967040.0,
59,716826,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as resting potential at 3 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = -60 +/- 1.1 mV),Other,22967040.0,
60,716827,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as input resistance at 0.03 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = 25.5 +/- 2.1 Momega),Other,22967040.0,
61,716828,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as input resistance at 0.1 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = 25.5 +/- 2.1 Momega),Other,22967040.0,
62,716829,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as input resistance at 0.3 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = 25.5 +/- 2.1 Momega),Other,22967040.0,
63,716830,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as input resistance at 0.6 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = 25.5 +/- 2.1 Momega),Other,22967040.0,
64,716831,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as input resistance at 1 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = 25.5 +/- 2.1 Momega),Other,22967040.0,
65,716832,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as input resistance at 3 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = 25.5 +/- 2.1 Momega),Other,22967040.0,
66,716833,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as maximum ascendant inclination at 0.03 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = 151.2 +/- 6.2 V/s),Other,22967040.0,
67,716834,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as maximum ascendant inclination at 0.1 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = 151.2 +/- 6.2 V/s),Other,22967040.0,
68,716835,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as maximum ascendant inclination at 0.3 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = 151.2 +/- 6.2 V/s),Other,22967040.0,
69,716836,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as maximum ascendant inclination at 0.6 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = 151.2 +/- 6.2 V/s),Other,22967040.0,
70,716837,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as maximum ascendant inclination at 1 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = 151.2 +/- 6.2 V/s),Other,22967040.0,
71,716838,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as maximum ascendant inclination at 3 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = 151.2 +/- 6.2 V/s),Other,22967040.0,
72,716839,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as maximum descendant inclination at 0.03 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = -104.7 +/- 3.6 V/s),Other,22967040.0,
73,716840,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as maximum descendant inclination at 0.1 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = -104.7 +/- 3.6 V/s),Other,22967040.0,
74,716841,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as maximum descendant inclination at 0.3 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = -104.7 +/- 3.6 V/s),Other,22967040.0,
75,716842,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as maximum descendant inclination at 0.6 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = -104.7 +/- 3.6 V/s),Other,22967040.0,
76,716843,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as maximum descendant inclination at 1 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = -104.7 +/- 3.6 V/s),Other,22967040.0,
77,716844,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as maximum descendant inclination at 3 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = -104.7 +/- 3.6 V/s),Other,22967040.0,
78,716845,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as duration at half maximal amplitute at 0.03 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = 1.6 +/- 0.1 ms),Other,22967040.0,
79,716846,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as duration at half maximal amplitute at 0.1 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = 1.6 +/- 0.1 ms),Other,22967040.0,
80,716847,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as duration at half maximal amplitute at 0.3 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = 1.6 +/- 0.1 ms),Other,22967040.0,
81,716848,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as duration at half maximal amplitute at 0.6 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = 1.6 +/- 0.1 ms),Other,22967040.0,
82,716849,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as duration at half maximal amplitute at 1 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = 1.6 +/- 0.1 ms),Other,22967040.0,
83,716850,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as duration at half maximal amplitute at 3 mM after 12 to 48 hrs by patch-clamp recordings (Rvb = 1.6 +/- 0.1 ms),Other,22967040.0,
84,716851,2,2,,103199240,10364,Unspecified,,,360.0,IC50,Blockade of action potential in Wistar rat DRG neuron after 12 to 48 hrs by patch-clamp recordings,Confirmatory,22967040.0,
85,716852,1,2,,103199240,10364,Unspecified,,,,,Effect on action potential in Wistar rat DRG neuron assessed as elevation in current threshold levels at 0.03 to 3 mM after 12 to 48 hrs by patch-clamp recordings relative to control,Other,22967040.0,
86,716853,1,2,,103199240,10364,Active,,,,,Inhibition of voltage-gated sodium channel of Wistar rat dissociated DRG neuron assessed as inhibition of current induced of voltage-gated sodium current at -100 mV holding potential with 5 sec intervals at 3 mM after 120 secs by patch-clamp recordings,Other,22967040.0,
87,716854,2,2,,103199240,10364,Unspecified,,,370.0,IC50,Inhibition of voltage-gated sodium channel of Wistar rat dissociated DRG neuron assessed as inhibition of current induced of voltage-gated sodium current at -100 mV holding potential with 5 sec intervals by patch-clamp recordings,Confirmatory,22967040.0,
88,716855,1,2,,103199240,10364,Unspecified,,,,,Inhibition of voltage-gated sodium channel of Sprague-Dawley rat dissociated DRG neuron assessed as inhibition of current induced of voltage-gated sodium current at -70 mV holding potential by patch-clamp recordings,Other,22967040.0,
89,720516,2,1,,144211695,10364,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
90,720552,2,1,,144211695,10364,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
91,720634,2,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
92,720635,2,1,,144211695,10364,Active,,,48.5577,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
93,720637,2,1,,144211695,10364,Inconclusive,,,48.5577,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
94,720674,2,2,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
95,720675,2,2,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
96,720678,2,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
97,720679,2,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
98,720680,2,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
99,720681,2,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
100,720682,2,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
101,720683,2,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
102,720684,2,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
103,720685,2,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
104,720686,2,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
105,720687,2,2,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
106,720691,4,1,,144211695,10364,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
107,720692,3,1,,144211695,10364,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
108,720693,3,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
109,720719,2,1,,144211695,10364,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
110,720725,2,1,,144211695,10364,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
111,722248,1,3,,103199240,10364,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity in ethanol solution at 50 ug/mL,Other,23273412.0,
112,722249,1,3,,103199240,10364,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity in ethanol solution at 100 ug/mL,Other,23273412.0,
113,722251,1,3,,103199240,10364,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity in ethanol solution at 25 ug/mL,Other,23273412.0,
114,722252,1,3,,103199240,10364,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity in ethanol solution at 5 ug/mL,Other,23273412.0,
115,722253,1,3,,103199240,10364,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity in ethanol solution at 10 ug/mL,Other,23273412.0,
116,722256,1,3,,103199240,10364,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity in ethanol solution,Other,23273412.0,
117,743012,3,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
118,743014,3,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
119,743015,3,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
120,743033,3,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
121,743035,2,1,,144211695,10364,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
122,743036,2,1,,144211695,10364,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
123,743040,3,1,,144211695,10364,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
124,743041,3,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
125,743042,3,1,,144211695,10364,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
126,743053,2,1,,144211695,10364,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
127,743054,2,1,,144211695,10364,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
128,743063,2,1,,144211695,10364,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
129,743064,3,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
130,743065,3,1,,144211695,10364,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
131,743066,3,1,,144211695,10364,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
132,743067,2,1,,144211695,10364,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
133,743069,2,1,,144211695,10364,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
134,743074,2,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
135,743075,2,1,,144211695,10364,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
136,743077,2,1,,144211695,10364,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
137,743078,2,1,,144211695,10364,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
138,743079,3,1,,144211695,10364,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
139,743080,3,1,,144211695,10364,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
140,743081,3,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
141,743083,3,1,,144211695,10364,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
142,743084,3,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
143,743085,3,1,,144211695,10364,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
144,743086,3,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
145,743091,2,1,,144211695,10364,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
146,743094,3,1,,144211695,10364,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
147,743122,2,1,,144211695,10364,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
148,743139,2,1,,144211695,10364,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
149,743140,2,1,,144211695,10364,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
150,743191,3,1,,144211695,10364,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
151,743194,3,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
152,743199,2,1,,144211695,10364,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
153,743202,4,1,,144211695,10364,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
154,743203,3,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
155,743209,3,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
156,743210,4,1,,144211695,10364,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
157,743211,3,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
158,743212,3,1,,144211695,10364,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
159,743213,3,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
160,743215,3,1,,144211695,10364,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
161,743217,3,1,,144211695,10364,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
162,743218,3,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
163,743219,3,1,,144211695,10364,Inactive,20149576.0,4780.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
164,743220,3,1,,144211695,10364,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
165,743221,3,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
166,743222,3,1,,144211695,10364,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
167,743223,3,1,,144211695,10364,Inconclusive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
168,743224,3,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
169,743225,3,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
170,743226,2,1,,144211695,10364,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
171,743227,2,1,,144211695,10364,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
172,743228,3,1,,144211695,10364,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
173,743239,2,1,,144211695,10364,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
174,743240,2,1,,144211695,10364,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
175,743241,2,1,,144211695,10364,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
176,743242,2,1,,144211695,10364,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
177,1081538,1,1,,103199240,10364,Unspecified,,,,,Nematicidal activity against Meloidogyne incognita J2 (root-knot nematode) larvae immersed in compound solution for 24 hr assessed as reduction in larval motility,Other,20527965.0,
178,1081539,1,1,,103199240,10364,Unspecified,,,,,Nematicidal activity against Meloidogyne incognita J2 (root-knot nematode) larvae immersed in compound solution for 48 hr assessed as reduction in larval motility,Other,20527965.0,
179,1081540,1,1,,103199240,10364,Unspecified,,,,,Nematicidal activity against Meloidogyne incognita J2 (root-knot nematode) larvae immersed in compound solution for 96 hr assessed as reduction in larval motility,Other,20527965.0,
180,1081541,1,1,,103199240,10364,Unspecified,,,,,Nematicidal activity against Meloidogyne javanica J2 (root-knot nematode) larvae immersed in compound solution for 48 hr assessed as reduction in larval motility,Other,20527965.0,
181,1081885,2,1,,103199240,10364,Unspecified,,,,,"Lipophilicity, logP of the compound",Other,21291237.0,
182,1081886,1,1,,103199240,10364,Unspecified,,,,,Repellent activity against Tribolium castaneum (red flour beetle) assessed as induction of repellency measured 4 hr post compound exposure at 0.2 uL/cm2 using 15% compound formulation,Other,21291237.0,
183,1081887,1,1,,103199240,10364,Unspecified,,,,,Repellent activity against Tribolium castaneum (red flour beetle) assessed as induction of repellency measured 4 hr post compound exposure at 0.02 uL/cm2 using 15% compound formulation,Other,21291237.0,
184,1081888,1,1,,103199240,10364,Unspecified,,,,,Repellent activity against Tribolium castaneum (red flour beetle) assessed as induction of repellency measured 4 hr post compound exposure at 0.002 uL/cm2 using 15% compound formulation,Other,21291237.0,
185,1081889,1,1,,103199240,10364,Unspecified,,,,,Repellent activity against Tribolium castaneum (red flour beetle) assessed as induction of repellency measured 4 hr post compound exposure at 0.0002 uL/cm2 using 15% compound formulation,Other,21291237.0,
186,1081890,1,1,,103199240,10364,Unspecified,,,,,Repellent activity against Tribolium castaneum (red flour beetle) assessed as induction of repellency measured 4 hr post compound exposure at 0.00002 uL/cm2 using 15% compound formulation,Other,21291237.0,
187,1081891,1,1,,103199240,10364,Unspecified,,,,,Repellent activity against Tribolium castaneum (red flour beetle) assessed as induction of repellency measured 2 hr post compound exposure at 0.2 uL/cm2 using 15% compound formulation,Other,21291237.0,
188,1081892,1,1,,103199240,10364,Unspecified,,,,,Repellent activity against Tribolium castaneum (red flour beetle) assessed as induction of repellency measured 2 hr post compound exposure at 0.02 uL/cm2 using 15% compound formulation,Other,21291237.0,
189,1081893,1,1,,103199240,10364,Unspecified,,,,,Repellent activity against Tribolium castaneum (red flour beetle) assessed as induction of repellency measured 2 hr post compound exposure at 0.002 uL/cm2 using 15% compound formulation,Other,21291237.0,
190,1081894,1,1,,103199240,10364,Unspecified,,,,,Repellent activity against Tribolium castaneum (red flour beetle) assessed as induction of repellency measured 2 hr post compound exposure at 0.0002 uL/cm2 using 15% compound formulation,Other,21291237.0,
191,1081895,1,1,,103199240,10364,Unspecified,,,,,Repellent activity against Tribolium castaneum (red flour beetle) assessed as induction of repellency measured 2 hr post compound exposure at 0.00002 uL/cm2 using 15% compound formulation,Other,21291237.0,
192,1090507,1,1,,103199240,10364,Unspecified,,,,,Antifungal activity against Colletotrichum gloeosporioides assessed as growth inhibition at 4 uL in 2 mM acetone by direct bioautography,Other,16939314.0,
193,1090508,1,1,,103199240,10364,Unspecified,,,,,Antifungal activity against Colletotrichum fragariae assessed as growth inhibition at 4 uL in 2 mM acetone by direct bioautography,Other,16939314.0,
194,1090509,1,1,,103199240,10364,Unspecified,,,,,Antifungal activity against Colletotrichum acutatum assessed as growth inhibition at 4 uL in 2 mM acetone by direct bioautography,Other,16939314.0,
195,1090796,1,1,,103199240,10364,Unspecified,,,,,Antifungal activity against Botryotinia fuckeliana assessed as growth inhibition at 30 uM by 96-well microdilution broth assay,Other,17894463.0,
196,1098327,1,1,,103199240,10364,Unspecified,,,,,Antifungal activity against Rhizoctonia solani,Other,23731643.0,
197,1112517,1,1,,103199240,10364,Unspecified,,,,,Toxicity to Musca domestica (house fly) applied to pronotum assessed as compound level per fly causing insect mortality measured after 24 hr,Other,22461383.0,
198,1112518,1,4,,103199240,10364,Unspecified,74919269.0,101900690.0,,,Displacement of [3H]TBOB binding to GABA receptor in Musca domestica (house fly) heads homogenates assessed as [3H]TBOB binding at 500 uM incubated for 90 min by scintillation counting method,Other,22461383.0,
199,1159509,1,1,,144211695,10364,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
200,1159515,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
201,1159516,1,1,,144211695,10364,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
202,1159517,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
203,1159518,1,1,,144211695,10364,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
204,1159519,1,1,,144211695,10364,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
205,1159520,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
206,1159521,1,1,,144211695,10364,Inactive,15928672.0,19885.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
207,1159523,1,1,,144211695,10364,Inactive,15928672.0,19885.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
208,1159525,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
209,1159526,1,1,,144211695,10364,Inconclusive,119627033.0,3725.0,54.941,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
210,1159527,1,1,,144211695,10364,Inactive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
211,1159528,1,1,,144211695,10364,Inconclusive,119627033.0,3725.0,54.941,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
212,1159529,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
213,1159531,1,1,,144211695,10364,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
214,1159551,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
215,1159552,1,1,,144211695,10364,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
216,1159553,2,1,,144211695,10364,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
217,1159555,1,1,,144211695,10364,Inactive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
218,1173467,1,1,,103199240,10364,Inactive,,,,,"Anticonvulsant activity in CF1 albino mouse assessed as protection against maximal electroshock-induced seizures at 100 mg/kg, ip after 0.25 hrs",Other,25454269.0,
219,1173468,1,1,,103199240,10364,Inactive,,,,,"Anticonvulsant activity in CF1 albino mouse assessed as protection against maximal electroshock-induced seizures at 100 mg/kg, ip after 0.5 hrs",Other,25454269.0,
220,1173469,1,1,,103199240,10364,Unspecified,,,,,"Anticonvulsant activity against CF1 albino mouse seizure model assessed as time to peak effect at 100 mg/kg, ip by 6 Hz psychomotor seizure test",Other,25454269.0,
221,1173470,1,1,,103199240,10364,Unspecified,,,,,Anticonvulsant activity against ip dosed CF1 albino mouse seizure model after 4 hrs by 6 Hz psychomotor seizure test,Other,25454269.0,
222,1173471,1,1,,103199240,10364,Unspecified,,,,,"Neurotoxicity in CF1 albino mouse seizure model assessed as time to peak toxic effect at 100 mg/kg, ip after 4 hr by rototod test",Other,25454269.0,
223,1173472,1,1,,103199240,10364,Unspecified,,,,,Neurotoxicity in ip dosed CF1 albino mouse seizure model after 4 hr by rototod test,Other,25454269.0,
224,1173473,1,1,,103199240,10364,Unspecified,,,,,"Protective index, ratio of TD50 for CF1 albino mouse neurotoxicity to ED50 for protection against 6 Hz electroshock-induced seizure in CF1 albino mouse",Other,25454269.0,
225,1173474,1,1,,103199240,10364,Inactive,,,,,"Anticonvulsant activity against CF1 albino mouse seizure model assessed as protection at 100 mg/kg, ip after 0.25 hrs by 6 Hz psychomotor seizure test",Other,25454269.0,
226,1173475,1,1,,103199240,10364,Inactive,,,,,"Anticonvulsant activity against CF1 albino mouse seizure model assessed as protection at 100 mg/kg, ip after 0.5 hrs by 6 Hz psychomotor seizure test",Other,25454269.0,
227,1173478,1,1,,103199240,10364,Unspecified,,,,,"Neurotoxicity in CF1 albino mouse seizure model at 100 mg/kg, ip after 0.25 hrs by rototod test",Other,25454269.0,
228,1173479,1,1,,103199240,10364,Unspecified,,,,,"Neurotoxicity in CF1 albino mouse seizure model at 100 mg/kg, ip after 0.5 hrs by rototod test",Other,25454269.0,
229,1173480,1,1,,103199240,10364,Unspecified,,,,,"Neurotoxicity in CF1 albino mouse seizure model at 100 mg/kg, ip after 1 hrs by rototod test",Other,25454269.0,
230,1173481,1,1,,103199240,10364,Unspecified,,,,,"Neurotoxicity in CF1 albino mouse seizure model at 100 mg/kg, ip after 2 hrs by rototod test",Other,25454269.0,
231,1173482,1,1,,103199240,10364,Unspecified,,,,,"Neurotoxicity in CF1 albino mouse seizure model at 100 mg/kg, ip after 4 hrs by rototod test",Other,25454269.0,
232,1173483,1,1,,103199240,10364,Inactive,,,,,"Anticonvulsant activity in CF1 albino mouse assessed as protection against maximal electroshock-induced seizures at 100 mg/kg, ip after 1 hrs",Other,25454269.0,
233,1173484,1,1,,103199240,10364,Inactive,,,,,"Anticonvulsant activity in CF1 albino mouse assessed as protection against maximal electroshock-induced seizures at 100 mg/kg, ip after 2 hrs",Other,25454269.0,
234,1173485,1,1,,103199240,10364,Unspecified,,,,,"Anticonvulsant activity in CF1 albino mouse assessed as protection against maximal electroshock-induced seizures at 100 mg/kg, ip after 4 hrs",Other,25454269.0,
235,1173486,1,1,,103199240,10364,Inactive,,,,,"Anticonvulsant activity in CF1 albino mouse assessed as protection against pentylenetetrazole-induced seizure at 100 mg/kg, ip after 0.25 hrs by scMET test",Other,25454269.0,
236,1173487,1,1,,103199240,10364,Inactive,,,,,"Anticonvulsant activity in CF1 albino mouse assessed as protection against pentylenetetrazole-induced seizure at 100 mg/kg, ip after 0.5 hrs by scMET test",Other,25454269.0,
237,1173489,1,1,,103199240,10364,Inactive,,,,,"Anticonvulsant activity in CF1 albino mouse assessed as protection against pentylenetetrazole-induced seizure at 100 mg/kg, ip after 2 hrs by scMET test",Other,25454269.0,
238,1173491,1,1,,103199240,10364,Inactive,,,,,"Anticonvulsant activity in CF1 albino mouse assessed as protection against Li-pilocarpine-induced seizure at 65 mg/kg, ip",Other,25454269.0,
239,1173494,1,1,,103199240,10364,Unspecified,,,,,"Anticonvulsant activity in CF1 albino mouse assessed as protection against pentylenetetrazole-induced seizure at 200 mg/kg, ip after 4 hrs by scMET test",Other,25454269.0,
240,1224834,3,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
241,1224835,1,1,,144211695,10364,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
242,1224836,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
243,1224837,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
244,1224838,1,1,,144211695,10364,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
245,1224839,1,1,,144211695,10364,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
246,1224840,3,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
247,1224841,3,1,,144211695,10364,Inactive,325495545.0,2101.0,48.5577,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
248,1224842,3,1,,144211695,10364,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
249,1224843,1,1,,144211695,10364,Inconclusive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
250,1224844,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
251,1224845,1,1,,144211695,10364,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
252,1224846,1,1,,144211695,10364,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
253,1224847,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
254,1224848,3,1,,144211695,10364,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
255,1224849,3,1,,144211695,10364,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
256,1224867,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
257,1224868,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
258,1224869,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
259,1224870,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
260,1224871,1,1,,144211695,10364,Inconclusive,,,48.9662,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
261,1224872,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
262,1224873,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
263,1224874,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
264,1224875,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
265,1224876,1,1,,144211695,10364,Inconclusive,,,54.941,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
266,1224877,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
267,1224878,1,1,,144211695,10364,Inconclusive,,,54.941,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
268,1224879,1,1,,144211695,10364,Inconclusive,,,54.941,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
269,1224880,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
270,1224881,1,1,,144211695,10364,Inconclusive,,,54.941,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
271,1224882,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
272,1224883,1,1,,144211695,10364,Inconclusive,,,54.941,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
273,1224884,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
274,1224885,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
275,1224886,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
276,1224887,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
277,1224888,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
278,1224889,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
279,1224890,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
280,1224892,1,1,,144211695,10364,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
281,1224893,1,1,,144211695,10364,Inactive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
282,1224894,1,1,,144211695,10364,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
283,1224895,1,1,,144211695,10364,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
284,1224896,1,1,,144211695,10364,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
285,1257262,1,1,,103199240,10364,Unspecified,,,98.0,IC50,Inhibition of Cav1.2 calcium current measured using whole cell patch clamp in dog ventricular myocytes,Confirmatory,,
286,1259241,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
287,1259242,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
288,1259243,1,1,,144211695,10364,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
289,1259244,1,1,,144211695,10364,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
290,1259247,1,1,,144211695,10364,Inactive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
291,1259248,1,1,,144211695,10364,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
292,1259364,1,1,,144211695,10364,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
293,1259365,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
294,1259366,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
295,1259367,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
296,1259368,1,1,,144211695,10364,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
297,1259369,1,1,,144211695,10364,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
298,1259377,1,1,,144211695,10364,Inconclusive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
299,1259378,1,1,,144211695,10364,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
300,1259379,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
301,1259380,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
302,1259381,1,1,,144211695,10364,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
303,1259382,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
304,1259383,1,1,,144211695,10364,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
305,1259384,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
306,1259385,1,1,,144211695,10364,Inconclusive,119601739.0,7253.0,0.4856,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
307,1259386,1,1,,144211695,10364,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
308,1259387,1,1,,144211695,10364,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
309,1259388,1,1,,144211695,10364,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
310,1259390,1,1,,144211695,10364,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
311,1259391,1,1,,144211695,10364,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
312,1259392,1,1,,144211695,10364,Inactive,109731339.0,2737.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
313,1259393,1,1,,144211695,10364,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
314,1259394,1,1,,144211695,10364,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
315,1259395,1,1,,144211695,10364,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
316,1259396,1,1,,144211695,10364,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
317,1259401,1,1,,144211695,10364,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
318,1259402,1,1,,144211695,10364,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
319,1259403,1,1,,144211695,10364,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
320,1259404,1,1,,144211695,10364,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
321,1259407,1,1,,363905400,10364,Active,,,,,CCRIS mutagenicity studies,Other,,
